Your browser doesn't support javascript.
loading
A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts.
Althoff, Keri N; Rebeiro, Peter F; Hanna, David B; Padgett, Denis; Horberg, Michael A; Grinsztejn, Beatriz; Abraham, Alison G; Hogg, Robert; Gill, M John; Wolff, Marcelo J; Mayor, Angel; Rachlis, Anita; Williams, Carolyn; Sterling, Timothy R; Kitahata, Mari M; Buchacz, Kate; Thorne, Jennifer E; Cesar, Carina; Cordero, Fernando M; Rourke, Sean B; Sierra-Madero, Juan; Pape, Jean W; Cahn, Pedro; McGowan, Catherine.
Afiliação
  • Althoff KN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; kalthoff@jhu.edu.
  • Rebeiro PF; Department of Medicine, Vanderbilt University, Nashville, TN, USA.
  • Hanna DB; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Padgett D; Department of Internal Medicine, Infectious Disease Service, Instituto Hondureño de Seguridad Social, Tegucigalpa, Honduras.
  • Horberg MA; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, MD, USA.
  • Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brasil.
  • Abraham AG; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Hogg R; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Gill MJ; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Wolff MJ; Departamento de Medicina, Facultad de Medicina, Universidad de Chile and Fundación Arriarán, Santiago, Chile.
  • Mayor A; Department of Internal Medicine, Universidad Central del Caribe, Bayamón, Puerto Rico, USA.
  • Rachlis A; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Williams C; Epidemiology, Basic Science Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Sterling TR; Department of Medicine, Vanderbilt University, Nashville, TN, USA.
  • Kitahata MM; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Buchacz K; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Thorne JE; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Cesar C; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Cordero FM; Investigaciones Clínicas, Fundación Huésped, Buenos Aires, Argentina, USA.
  • Rourke SB; HIV Research Group, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú
  • Sierra-Madero J; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Pape JW; Departamento de Infectología, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico DF, Mexico.
  • Cahn P; Le Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti and Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • McGowan C; Investigaciones Clínicas, Fundación Huésped, Buenos Aires, Argentina, USA.
J Int AIDS Soc ; 19(1): 20707, 2016.
Article em En | MEDLINE | ID: mdl-27049052
ABSTRACT

INTRODUCTION:

Maps are powerful tools for visualization of differences in health indicators by geographical region, but multi-country maps of HIV indicators do not exist, perhaps due to lack of consistent data across countries. Our objective was to create maps of four HIV indicators in North, Central, and South American countries.

METHODS:

Using data from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) and the Caribbean, Central, and South America network for HIV epidemiology (CCASAnet), we mapped median CD4 at presentation for HIV clinical care, proportion retained in HIV primary care, proportion prescribed antiretroviral therapy (ART), and the proportion with suppressed plasma HIV viral load (VL) from 2010 to 2012 for North, Central, and South America. The 15 Canadian and US clinical cohorts and 7 clinical cohorts in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru represented approximately 2-7% of persons known to be living with HIV in these countries.

RESULTS:

Study populations were selected for each indicator median CD4 at presentation for care was estimated among 14,811 adults; retention was estimated among 87,979 adults; ART use was estimated among 84,757 adults; and suppressed VL was estimated among 51,118 adults. Only three US states and the District of Columbia had a median CD4 at presentation >350 cells/mm(3). Haiti, Mexico, and several states had >85% retention in care; lower (50-74%) retention in care was observed in the US West, South, and Mid-Atlantic, and in Argentina, Brazil, and Peru. ART use was highest (90%) in Mexico. The percentages of patients with suppressed VL in the US South and Northeast were lower than in most of Central and South America.

CONCLUSIONS:

These maps provide visualization of gaps in the quality of HIV care and allow for comparison between and within countries as well as monitoring policy and programme goals within geographical boundaries.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV Idioma: En Ano de publicação: 2016 Tipo de documento: Article